0001628280-24-006421.txt : 20240222
0001628280-24-006421.hdr.sgml : 20240222
20240222171824
ACCESSION NUMBER: 0001628280-24-006421
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240220
FILED AS OF DATE: 20240222
DATE AS OF CHANGE: 20240222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Haurwitz Rachel E.
CENTRAL INDEX KEY: 0001670579
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40631
FILM NUMBER: 24666151
MAIL ADDRESS:
STREET 1: C/O CARIBOU BIOSCIENCES, INC.
STREET 2: 2929 7TH STREET, SUITE 105
CITY: BERKELEY
STATE: CA
ZIP: 94710
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Caribou Biosciences, Inc.
CENTRAL INDEX KEY: 0001619856
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 453728228
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2929 7TH STREET, SUITE 105
CITY: BERKELEY
STATE: CA
ZIP: 94710
BUSINESS PHONE: 510-982-6030
MAIL ADDRESS:
STREET 1: 2929 7TH STREET, SUITE 105
CITY: BERKELEY
STATE: CA
ZIP: 94710
4
1
wk-form4_1708640281.xml
FORM 4
X0508
4
2024-02-20
0
0001619856
Caribou Biosciences, Inc.
CRBU
0001670579
Haurwitz Rachel E.
C/O CARIBOU BIOSCIENCES, INC.
2929 7TH STREET, SUITE 105
BERKELEY
CA
94710
1
1
0
0
President and CEO
0
Common Stock
2024-02-20
4
A
0
118700
0
A
158700
D
Common Stock
3349395
I
By Trust
Option to purchase Common Stock
6.81
2024-02-20
4
A
0
546950
0
A
2034-02-19
Common Stock
546950
546950
D
This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2025, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date.
Shares are held by The City Canyon Family Trust dated May 31, 2021, of which the Reporting Person is a Co-Trustee with her spouse.
25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2025, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.
/s/ Barbara G. McClung, as attorney-in-fact
2024-02-22